Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.

Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ, Miller DS, Huang TH.

Cancer Res. 2009 Dec 1;69(23):9038-46. doi: 10.1158/0008-5472.CAN-09-1499. Epub 2009 Nov 3.

PMID:
19887623
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Hypermethylation of miR-203 in endometrial carcinomas.

Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, Rader JS, Uyar DS.

Gynecol Oncol. 2014 May;133(2):340-5. doi: 10.1016/j.ygyno.2014.02.009. Epub 2014 Feb 14.

PMID:
24530564
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.

Shen R, Pan S, Qi S, Lin X, Cheng S.

Biochem Biophys Res Commun. 2010 Apr 16;394(4):1047-52. doi: 10.1016/j.bbrc.2010.03.121. Epub 2010 Mar 21.

PMID:
20331975
[PubMed - indexed for MEDLINE]
4.

miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.

Kang M, Li Y, Liu W, Wang R, Tang A, Hao H, Liu Z, Ou H.

Int J Mol Med. 2013 Jul;32(1):51-8. doi: 10.3892/ijmm.2013.1384. Epub 2013 May 16.

PMID:
23677061
[PubMed - indexed for MEDLINE]
5.

Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.

Kanaya T, Kyo S, Maida Y, Yatabe N, Tanaka M, Nakamura M, Inoue M.

Oncogene. 2003 Apr 17;22(15):2352-60.

PMID:
12700670
[PubMed - indexed for MEDLINE]
6.

Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.

Zighelboim I, Goodfellow PJ, Gao F, Gibb RK, Powell MA, Rader JS, Mutch DG.

J Clin Oncol. 2007 May 20;25(15):2042-8.

PMID:
17513808
[PubMed - indexed for MEDLINE]
7.

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.

Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J.

Cancer Res. 2011 Oct 15;71(20):6450-62. doi: 10.1158/0008-5472.CAN-11-0364. Epub 2011 Aug 25.

PMID:
21868754
[PubMed - indexed for MEDLINE]
Free Article
8.

Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.

Zhang X, Dong Y, Ti H, Zhao J, Wang Y, Li T, Zhang B.

Hum Pathol. 2013 Nov;44(11):2571-80. doi: 10.1016/j.humpath.2013.07.002. Epub 2013 Sep 24.

PMID:
24071015
[PubMed - indexed for MEDLINE]
9.

Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.

Saegusa M, Hashimura M, Kuwata T.

Lab Invest. 2012 Apr;92(4):511-21. doi: 10.1038/labinvest.2011.196. Epub 2012 Jan 9.

PMID:
22231735
[PubMed - indexed for MEDLINE]
Free Article
10.

Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.

Chen Y, Gao W, Luo J, Tian R, Sun H, Zou S.

Oncol Rep. 2011 Feb;25(2):443-51. doi: 10.3892/or.2010.1089. Epub 2010 Dec 9.

PMID:
21165562
[PubMed - indexed for MEDLINE]
11.

[Epigenetic inactivation of microRNA genes in mammary carcinoma].

Lehmann U, Hasemeier B, Römermann D, Müller M, Länger F, Kreipe H.

Verh Dtsch Ges Pathol. 2007;91:214-20. German.

PMID:
18314617
[PubMed - indexed for MEDLINE]
12.

MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.

Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y, Yin LR.

FEBS J. 2013 Aug;280(16):3768-79. doi: 10.1111/febs.12365. Epub 2013 Jun 27.

PMID:
23731275
[PubMed - indexed for MEDLINE]
13.

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.

Romero-Pérez L, Castilla MÁ, López-García MÁ, Díaz-Martín J, Biscuola M, Ramiro-Fuentes S, Oliva E, Matias-Guiu X, Prat J, Cano A, Moreno-Bueno G, Palacios J.

Hum Pathol. 2013 Feb;44(2):244-54. doi: 10.1016/j.humpath.2012.05.013. Epub 2012 Sep 10.

PMID:
22974476
[PubMed - indexed for MEDLINE]
14.

Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair.

Helmle KE, Otto CJ, Constantinescu G, Honore LH, Andrew SE.

Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1089-96.

PMID:
16343186
[PubMed - indexed for MEDLINE]
15.

Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.

Rodríguez-Jiménez FJ, Caldés T, Iniesta P, Vidart JA, Garcia-Asenjo JL, Benito M.

Oncol Rep. 2007 Jun;17(6):1301-7.

PMID:
17487382
[PubMed - indexed for MEDLINE]
16.

Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.

Liao X, Siu MK, Chan KY, Wong ES, Ngan HY, Chan QK, Li AS, Khoo US, Cheung AN.

Int J Cancer. 2008 Jul 15;123(2):296-302. doi: 10.1002/ijc.23494.

PMID:
18404674
[PubMed - indexed for MEDLINE]
17.

A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.

Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang P, Chan LK, Zhang T, Yu J, Kwong J, Cheung TH, Chung T, Mak K, Sun H, Wang H.

Oncogene. 2013 Jul 18;32(29):3432-42. doi: 10.1038/onc.2012.360. Epub 2012 Aug 20.

PMID:
22907428
[PubMed - indexed for MEDLINE]
18.

Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.

Peterson LM, Kipp BR, Halling KC, Kerr SE, Smith DI, Distad TJ, Clayton AC, Medeiros F.

Int J Gynecol Pathol. 2012 May;31(3):195-205. doi: 10.1097/PGP.0b013e318231fc51.

PMID:
22498935
[PubMed - indexed for MEDLINE]
19.

Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC.

Chen X, Zhang L, Zhang T, Hao M, Zhang X, Zhang J, Xie Q, Wang Y, Guo M, Zhuang H, Lu F.

Liver Int. 2013 Mar;33(3):476-86. doi: 10.1111/liv.12097.

PMID:
23402613
[PubMed - indexed for MEDLINE]
20.

Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.

Catasus L, Pons C, Muñoz J, Espinosa I, Prat J.

Histopathology. 2013 Mar;62(4):632-41. doi: 10.1111/his.12047. Epub 2013 Feb 5.

PMID:
23379820
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk